Cas 342435-24-9,Morpholine, 4-[2-(3-methoxy-4-nitrophenoxy)ethyl]-

342435-24-9

Post Buying Request

Basic information

Product Name: Morpholine, 4-[2-(3-methoxy-4-nitrophenoxy)ethyl]-
Synonyms:
CAS NO:342435-24-9
Molecular Formula: C13H18N2O5
Molecular Weight: 282.296
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: Morpholine, 4-[2-(3-methoxy-4-nitrophenoxy)ethyl]-(CAS DataBase Reference)
NIST Chemistry Reference: Morpholine, 4-[2-(3-methoxy-4-nitrophenoxy)ethyl]-(342435-24-9)
EPA Substance Registry System: Morpholine, 4-[2-(3-methoxy-4-nitrophenoxy)ethyl]-(342435-24-9)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 342435-24-9(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

342435-24-9 Suppliers

Recommended suppliers

342435-24-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 342435-24-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,4,2,4,3 and 5 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 342435-24:
(8*3)+(7*4)+(6*2)+(5*4)+(4*3)+(3*5)+(2*2)+(1*4)=119
119 % 10 = 9
So 342435-24-9 is a valid CAS Registry Number.

342435-24-9Upstream product

342435-24-9Downstream Products

342435-24-9Relevant academic research and scientific papers

A class of FLT3 kinase inhibitors, preparation and application thereof

-

Paragraph 0262; 0265-0267, (2020/06/20)

The invention relates to a class of FLT3 kinase inhibitors, preparation and application thereof, wherein specifically the compound has a structure represented by a formula (I), and all groups and substituents are defined in the specification. The invention also discloses a preparation method of the compound, and application of the compound in inhibition of FLT3.

NEW SUBSTITUTED AZAINDOLINE DERIVATIVES AS NIK INHIBITORS

-

Page/Page column 136; 140, (2019/01/21)

The present invention relates to pharmaceutical agents useful for therapy and/or prophylaxis in a mammal, and in particular to inhibitors of NF-κB-inducing kinase (NIK - also known as MAP3K14) useful for treating diseases such as cancer, inflammatory disorders, metabolic disorders and autoimmune disorders. The invention is also directed to pharmaceutical compositions comprising such compounds, and to the use of such compounds or pharmaceutical compositions for the prevention or treatment of diseases such as cancer, inflammatory disorders, metabolic disorders including obesity and diabetes, and autoimmune disorders.

Imidazopyridazine IRAK4 inhibitor, and preparation method and application thereof

-

Paragraph 0276; 0277; 0278, (2018/03/26)

The invention belongs to the field of medicines, and especially relates to an imidazopyridazine compound or a pharmaceutically acceptable salt thereof, a preparation method thereof, and an applicationof a medicinal composition of the compound or the salt in the treatment of tumors, inflammations, immunity and other diseases. The imidazopyridazine compound is a novel protein kinase IRAK4 inhibitor, and can selectively inhibit IRAK4 and downstream signaling pathways thereof. The compound has the structural formula I.

NOVEL COMPOUNDS

-

Page/Page column 111, (2008/06/13)

There is provided a compound of formula (I): processes for the manufacture thereof, pharmaceutical compositions thereof and uses in therapy.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 342435-24-9